WCPD 2025
Real-world evidence (RWE) in clinical trials refers to data obtained from sources outside traditional clinical research settings, such as electronic health records, claims and billing data, patient registries, and wearable devices. By incorporating RWE into clinical trials, researchers can obtain a more comprehensive understanding of how treatments work in real-world scenarios beyond the controlled environment of a traditional trial. This allows for insights into factors such as patient demographics, co-morbidities, treatment adherence, and long-term outcomes that may not be captured in a lab setting. Utilizing RWE can help inform decisions around drug development, regulatory approvals, and healthcare policy-making by providing a more complete picture of treatment efficacy and safety. However, it is important to ensure the quality and reliability of RWE sources to maintain the integrity of the study findings.
- Real-World Evidence
- Clinical Trials
- Patient-Centric
- Pharmaceutical Interventions
Related Sessions
Tags
- Real-World Evidence Conferences 2025
- Clinical Trials with Real-World Evidence
- Real-World Evidence Events 2025
- Clinical Trials Symposium
- Real-World Evidence Summit 2025
- Clinical Trials Innovations
- Real-World Evidence Webinar 2025
- Clinical Trials Congress 2025
- Real-World Evidence Meetings 2025
- Clinical Trials Hybrid Event 2025
- Real-World Evidence in Pharmaceuticals
- Clinical Trials Event USA
- Real-World Evidence 2025 USA
- Clinical Trials Innovations
- Real-World Evidence in Drug Development
- Clinical Trials Congress
- Real-World Evidence Summit 2025
- Real-World Evidence 2025 Events
- Upcoming Clinical Trials Events 2025